NasdaqGM - Nasdaq Real Time Price USD
Xenon Pharmaceuticals Inc. (XENE)
30.29
+0.72
+(2.43%)
At close: May 16 at 4:00:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 13 | 13 | 14 | 14 |
| Avg. Estimate | -0.99 | -1.07 | -4.03 | -4.36 |
| Low Estimate | -1.1 | -1.25 | -4.48 | -5.74 |
| High Estimate | -0.8 | -0.86 | -3.43 | -2.05 |
| Year Ago EPS | -0.75 | -0.81 | -3.01 | -4.03 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 15 | 15 | 17 | 16 |
| Avg. Estimate | -- | -- | 7.38M | 20.78M |
| Low Estimate | -- | -- | 5M | -- |
| High Estimate | -- | -- | 8M | 200M |
| Year Ago Sales | -- | -- | -- | 7.38M |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 181.55% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.68 | -0.79 | -0.84 | -0.9 |
| EPS Actual | -0.75 | -0.81 | -0.84 | -0.83 |
| Difference | -0.07 | -0.02 | -0 | 0.07 |
| Surprise % | -10.65% | -2.52% | -0.09% | 7.49% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.99 | -1.07 | -4.03 | -4.36 |
| 7 Days Ago | -0.99 | -1.07 | -4.06 | -4.35 |
| 30 Days Ago | -0.98 | -1.06 | -4.05 | -4.55 |
| 60 Days Ago | -0.99 | -1.07 | -4.07 | -4.29 |
| 90 Days Ago | -0.88 | -0.92 | -3.65 | -4.06 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 5 | 4 | 5 | 5 |
| Up Last 30 Days | 4 | 4 | 5 | 4 |
| Down Last 7 Days | 7 | 5 | 3 | 5 |
| Down Last 30 Days | 7 | 5 | 3 | 5 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| XENE | -31.55% | -31.52% | -33.89% | -8.08% |
| S&P 500 | 13.31% | 2.67% | 7.78% | 13.74% |
Upgrades & Downgrades
| Initiated | Evercore ISI Group: Outperform | 5/14/2025 |
| Maintains | Wells Fargo: Overweight to Overweight | 5/13/2025 |
| Maintains | RBC Capital: Outperform to Outperform | 5/13/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/13/2025 |
| Maintains | Needham: Buy to Buy | 5/13/2025 |
| Maintains | Chardan Capital: Buy to Buy | 5/13/2025 |
Related Tickers
HALO Halozyme Therapeutics, Inc.
52.02
+6.27%
LEGN Legend Biotech Corporation
27.78
+0.33%
CRNX Crinetics Pharmaceuticals, Inc.
31.24
+0.10%
BHVN Biohaven Ltd.
16.02
+1.26%
AKRO Akero Therapeutics, Inc.
38.87
-2.73%
CYTK Cytokinetics, Incorporated
31.00
+3.89%
BBIO BridgeBio Pharma, Inc.
33.84
+0.30%
TVTX Travere Therapeutics, Inc.
16.80
-20.57%
IMVT Immunovant, Inc.
14.46
+3.88%
PCVX Vaxcyte, Inc.
31.85
+3.07%